In parallel, CDK4/6 inhibition hampers tumour progression, therefore promoting the accumulation and maturation of NK cells, a further critical component of the tumour immunosurveillance from which may arise the natural killer/T-cell lymphoma (NKTL) [34, 111, 146]. The gene discussed is SCYL1; the disease is neoplasm.